Skip to Main Content

Paper Details

The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology.
Alzheimers Dement
33
2021
AD, AD dementia, Alzheimer's, Alzheimer's Disease, Alzheimer's disease, DNA, EOAD, MCI, Participants, Patients, RNA, [18 F]Florbetaben, [18 F]Flortaucipir, amyloid beta (A), mild cognitive impairment, peripheral blood mononuclear cells
Author NameAffiliation
Liana G ApostolovaIndiana University School of Medicine
Liana G ApostolovaCenter for Neuroimaging, Indiana University School of Medicine Indianapolis
Liana G ApostolovaIndiana University School of Medicine
Paul S AisenAlzheimer's Therapeutic Research Institute, University of Southern California
Tatiana ForoudIndiana University School of Medicine
Clifford R JackMayo Clinic
Joel H KramerUniversity of California san francisco
Robert A KoeppeUniversity of Michigan ann arbor
Malia RumbaughIndiana University School of Medicine
Arthur W TogaUSC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC
Arthur W TogaUSC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC
Neill R Graff-RadfordMayo Clinic
Lawrence S HonigTaub Institute and Department of Neurology, Columbia University Irving Medical Center
Chiadi U OnyikeJohns Hopkins University School of Medicine
Stephen SallowayAlpert Medical School, Brown University
David A WolkPerelman School of Medicine, University of Pennsylvania
  • 1 - 16

Datasets

Release 1.2